Literature DB >> 22828806

Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.

Venu Gopala Reddy Gangireddy1, Teresa A Coleman, Akash Nabh, Subbaramiah Sridhar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828806     DOI: 10.1007/s10620-012-2302-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  34 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 2.  Autoimmune hepatitis.

Authors:  Edward L Krawitt
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

3.  AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Authors:  James B Bussel; David J Kuter; James N George; Robert McMillan; Louis M Aledort; George T Conklin; Alan E Lichtin; Roger M Lyons; Jorge Nieva; Jeffrey S Wasser; Israel Wiznitzer; Reggie Kelly; Chien-Feng Chen; Janet L Nichol
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

4.  Significance of laparoscopic splenectomy in patients with hypersplenism.

Authors:  Yuji Watanabe; Atsushi Horiuchi; Motohira Yoshida; Yuji Yamamoto; Hiroki Sugishita; Teru Kumagi; Yoichi Hiasa; Kanji Kawachi
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

5.  Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study.

Authors:  Yuji Kumagai; Tomoe Fujita; Machiko Ozaki; Kunihiko Sahashi; Masayuki Ohkura; Tomoko Ohtsu; Yoshihiro Arai; Yusuke Sonehara; Janet L Nichol
Journal:  J Clin Pharmacol       Date:  2007-10-09       Impact factor: 3.126

6.  Thrombocytopenia caused by the development of antibodies to thrombopoietin.

Authors:  J Li; C Yang; Y Xia; A Bertino; J Glaspy; M Roberts; D J Kuter
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

7.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

8.  Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.

Authors:  M A Elliott; M G Chen; M N Silverstein; A Tefferi
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

9.  Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

10.  Autoimmune thrombocytopenia associated with hepatitis C virus infection.

Authors:  F Hernández; A Blanquer; M Linares; A López; F Tarín; A Cerveró
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.